Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis.

Ferrari E, Engelen M, Monzani E, Sturini M, Girotto S, Bubacco L, Zecca L, Casella L.

J Biol Inorg Chem. 2013 Jan;18(1):81-93. doi: 10.1007/s00775-012-0951-7. Epub 2012 Oct 31.

PMID:
23111628
2.

Synthesis, Structure Characterization, and Evaluation in Microglia Cultures of Neuromelanin Analogues Suitable for Modeling Parkinson's Disease.

Ferrari E, Capucciati A, Prada I, Zucca FA, D'Arrigo G, Pontiroli D, Bridelli MG, Sturini M, Bubacco L, Monzani E, Verderio C, Zecca L, Casella L.

ACS Chem Neurosci. 2017 Mar 15;8(3):501-512. doi: 10.1021/acschemneuro.6b00231. Epub 2016 Nov 28.

PMID:
28292181
3.

Iron-binding characteristics of neuromelanin of the human substantia nigra.

Double KL, Gerlach M, Sch√ľnemann V, Trautwein AX, Zecca L, Gallorini M, Youdim MB, Riederer P, Ben-Shachar D.

Biochem Pharmacol. 2003 Aug 1;66(3):489-94.

PMID:
12907248
5.

Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy.

Haining RL, Jones TM, Hernandez A.

Neurochem Res. 2016 Dec;41(12):3356-3363. Epub 2016 Sep 23.

PMID:
27662849
6.

Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study.

Shima T, Sarna T, Swartz HM, Stroppolo A, Gerbasi R, Zecca L.

Free Radic Biol Med. 1997;23(1):110-9.

PMID:
9165303
7.

Is neuromelanin changed in Parkinson's disease? Investigations by magnetic spectroscopies.

Fasano M, Bergamasco B, Lopiano L.

J Neural Transm (Vienna). 2006 Jun;113(6):769-74. Epub 2006 May 12. Review.

PMID:
16755381
8.

The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems.

Zareba M, Bober A, Korytowski W, Zecca L, Sarna T.

Biochim Biophys Acta. 1995 Jun 9;1271(2-3):343-8.

9.

Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease.

Fedorow H, Tribl F, Halliday G, Gerlach M, Riederer P, Double KL.

Prog Neurobiol. 2005 Feb;75(2):109-24. Review.

PMID:
15784302
10.

Interaction of neuromelanin and iron in substantia nigra and other areas of human brain.

Zecca L, Shima T, Stroppolo A, Goj C, Battiston GA, Gerbasi R, Sarna T, Swartz HM.

Neuroscience. 1996 Jul;73(2):407-15.

PMID:
8783258
11.
12.

Iron, melanin and dopamine interaction: relevance to Parkinson's disease.

Ben-Shachar D, Youdim MB.

Prog Neuropsychopharmacol Biol Psychiatry. 1993 Jan;17(1):139-50.

PMID:
8416600
13.

Modifications of the iron-neuromelanin system in Parkinson's disease.

Fasano M, Bergamasco B, Lopiano L.

J Neurochem. 2006 Feb;96(4):909-16. Epub 2006 Jan 17. Review.

14.

The structure of neuromelanin and its iron binding site studied by infrared spectroscopy.

Bridelli MG, Tampellini D, Zecca L.

FEBS Lett. 1999 Aug 20;457(1):18-22.

15.

Total and paramagnetic metals in human substantia nigra and its neuromelanin.

Zecca L, Swartz HM.

J Neural Transm Park Dis Dement Sect. 1993;5(3):203-13.

PMID:
8396395
16.

Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients.

Lopiano L, Chiesa M, Digilio G, Giraudo S, Bergamasco B, Torre E, Fasano M.

Biochim Biophys Acta. 2000 Mar 17;1500(3):306-12.

17.

Functional effects of neuromelanin and synthetic melanin in model systems.

Double KL.

J Neural Transm (Vienna). 2006 Jun;113(6):751-6. Epub 2006 May 5. Review.

PMID:
16755379
18.

Neuromelanins of human brain have soluble and insoluble components with dolichols attached to the melanic structure.

Engelen M, Vanna R, Bellei C, Zucca FA, Wakamatsu K, Monzani E, Ito S, Casella L, Zecca L.

PLoS One. 2012;7(11):e48490. doi: 10.1371/journal.pone.0048490. Epub 2012 Nov 5.

19.

Isolation and 13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease.

Aime S, Bergamasco B, Casu M, Digilio G, Fasano M, Giraudo S, Lopiano L.

Mov Disord. 2000 Sep;15(5):977-81.

PMID:
11009208
20.

EPR investigations of the iron domain in neuromelanin.

Aime S, Bergamasco B, Biglino D, Digilio G, Fasano M, Giamello E, Lopiano L.

Biochim Biophys Acta. 1997 Jul 10;1361(1):49-58.

Supplemental Content

Support Center